Targeting of hepatitis C virus core protein for MHC I or MHC II presentation does not enhance induction of immune responses to DNA vaccination

DNA and Cell Biology

Volumn 18, Issue 8, 1999, Pages 611-621

  Vidalin, O ^a   Tanaka, E ^b   Spengler, U ^c   Trepo C ^a   Inchauspe G ^a  

^a INSERM   (France)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Allgemeine Innere Medizin   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; CYTOKINE; DNA VACCINE; MEMBRANE PROTEIN; UBIQUITIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HELPER CELL; HEPATITIS C VIRUS; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD; BIOLOGICAL TRANSPORT; CELLS, CULTURED; CYTOKINES; EPITOPE MAPPING; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIGENS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; LYMPHOCYTE ACTIVATION; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; PROTEIN SORTING SIGNALS; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; UBIQUITINS; VACCINES, DNA; VIRAL CORE PROTEINS; VIRAL HEPATITIS VACCINES;

ANIMALIA; HEPATITIS C VIRUS;

EID: 0032785706     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454999315024     Document Type: Article

References (54)

1. ABRIGNANI, S. (1997). Immune responses throughout hepatitis C virus (HCV) infection: HCV from the immune system point of view. Semin. Immunpathol. 19, 47-55.
2. AMIGORENA, S., DRAKE, J. R., WEBSTER, P., and MELLMAN, I. (1994). Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes. Nature 369, 113-120.
3. BARRY, M. A., LAI, W. C., and JOHNSON S. A. (1995). Protection against mycoplasma infection using expression-library immunization. Nature 377, 632-635.
4. BATTEGAY, M., FIKES, J., DI BISCEGLIE, A. M., WENTWORTH, P. A., SETTE, A., CELIS, E., CHING, W., GRAKOUI, A., RICE, C. M., KUROKOCHI, K., BERZOFSKY, J. A., HOOFNAGEL, J. H., FEINSTONE, S. M., and AKATSUKA T. (1995). Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize C virus-encoded peptides binding to HLA-A2.1 molecules. J. Virol. 69, 2462-2470.
5. BRUNA-ROMERO, O., LASARTE, J. J., WILKINSON, G., GRACE, K., CLARKE, B., BORRAS-CUESTA, F., and PRIETO, J. (1997). Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus. Hepatology 25, 470-477.
6. BUKH, J., PURCELL, R. H., and MILLER, R. H. (1994). Sequence analysis of the core gene of 14 hepatitis C virus genotypes. Proc. Natl. Acad. Sci. USA 91, 8239-8243.
7. CASTELLINO, F., and GERMAIN, R. N. (1995). Extensive trafficking of MHC class II-invariant chain complexes in the endocytic pathway and appearance of peptide-loaded class II in multiple compartments. Immunity 2, 73-88.
8. CERNY, A., McHUTCHISON, J. G., PASQUINELLI, C., BROWN, M. E., BROTHERS, M. A., GRABSCHEID, B., FOWLER, P., HOUGHTON, M., and CHISARI, F. V. (1995). Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J. Clin. Invest. 95, 521-530.
9. CHANG, K.-M., GRUENER, N. H., SOUTHWOOD, S., SIDNEY, J., PAPE, G. R., CHISARI, F. V., and SETTE, A. (1999). Identification of HLA-A3 and -B7 restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C. J. Immunol. 162, 1156-1164.
10. CHEN, J. W., MURPHY, T. L., WILLINGHAM, M. C., PASTAN, I., and AUGUST, J. T. (1985). Identification of two lysosomal membrane glycoproteins. J. Cell Biol. 101, 85-95.
11. CHOO, QL. L., KUO, G., WEINER, A. J., OVERBY, L. R., BRADLEY, D. W., and HOUGHTON, M. (1989). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244, 359-362.
12. CHOO, Q. L., RICHMAN, K. H., HAN, J. H., BERGER, K., LEE, C., DONG, C., GALLEGOS, C., COIT, D., MEDINA-SELBY, R., BARR, P. J., WEINER, A. J., BRADLEY, D. W., KUO, G., and HOUGHTON, M. (1991). Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. USA 88, 2451-2455.
13. CIECHANOVER, A. (1994). The ubiquitin-proteosome proteolytic pathway. Cell 79, 13-21.
14. COX, J. H., GALARDY, P., BENNINK, J. R., and YEWDELL, J. W. (1995). Presentation of endogenous and exogenous antigens is not affected by inactivation of E1 ubiquitin-activating enzyme in temperature-sensitive cell lines. J. Immunol. 154, 511-519.
15. + T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J. Virol. 71, 6011-6019.
16. EAGER, K. B., HACKETT, C. J., GERHARD, W. U., BENNINK, J., EISENLOHR, L. C., YEWDELL, J. and RICCIARDI, R. (1989). Murine cell lines stably expressing the influenza virus hemagglutinin gene introduced by a recombinant retrovirus vector are constitutive targets for MHC class I- and class II-restricted T lymphocytes. J. Immunol. 143, 2328-2335.
17. ECKER, D. J., STADEL, J. M., BUTT, T. R., MARSH, I. A., MONIA, B. P., POWERS, D. A., GORMAN, J. A., CLARK, P. E., WARREN, F., and SHATZMAN, A. (1989). Increasing gene expression in yeast by fusion to ubiquitin. J. Biol. Chem. 264, 7715-7719.
18. FU, T.-M., GUAN, L., FRIEDMAN, A., ULMER, J. B., LIU, M. A., and DONNELLY, J. J. (1998). Induction of MHC class I-restricted CTL response by DNA immunization with ubiquitin-influenza virus nucleoprotein fusion antigens. Vaccine 16, 1711-1717.
19. GEISSLER, M., GESIEN, A., TOKUSHIGE, K., and WANDS, J. R. (1997a). Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J. Immunol. 158, 1231-1237.
20. GEISSLER, M., SCHIRMBECK, R., REIMANN, J., BLUM, H. E., and WANDS, J. R. (1998a). Cytokine and hepatitis B virus DNA coimmunizations enhance cellular and humoral immune responses to the middle but not to the large hepatitis B virus surface antigen in mice. Hepatology 28, 202-210.
21. GEISSLER, M., TOKUSHIGE, K., CHANTE, C. C., ZURAWSKI, V. R., and WANDS, J. R. (1997b). Cellular and humoral immune response to hepatitis B virus structural proteins in mice after DNA-based immunization. Gastroenterology 112, 1307-1320.
22. GEISSLER, M., TOKUSHIGE, K., WAKITA, T., ZURAWSKI, V. R., and WANDS, J. R. (1998b). Differential cellular and humoral immune responses to HCV core and HBV envelope proteins after genetic immunizations using chimeric constructs. Vaccine 16, 857-867.
23. GOTH, S., NGUYEN, V., and SHASTRI, N. (1996). Generation of naturally processed peptide/MHC class I complexes is independent of the stability of endogenously synthesized precursors. J. Immunol. 157, 1894-1904.
24. GUARNIERI, F. G., ARTERBURN, L. M., PENNO, M. B., CHA, Y., and AUGUST, J. T. (1993). The motif Tyr-X-X-hydrophobic residue mediates lysosomal membrane targeting of lysosome-associated membrane protein 1. J. Biol. Chem. 268, 1941-1946.
25. HARDING, C. V., and GEUZE, H. (1993). Immunogenic peptides bind to class II MHC molecules in an early lysosomal compartment. J. Immunol. 151, 3988-3998.
26. HARDING, C. V., and GEUZE, H. J. (1992). Class II MHC molecules are present in macrophage lysosomes and phagolysosomes that function in the phagocytic processing of Listeria monocytogenes for presentation to T cells. J. Immunol. 119, 531-542.
27. + T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatology 21, 632-638.
28. INCHAUSPÉ, G., VITVITSKI, L., MAJOR, M. E., JUNG, G., SPENGLER, U., MAISONNAS, M., and TRÉPO C. (1997). Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: comparative studies of antibody and T-helper responses following genetic immunization. DNA Cell Biol. 16, 182-195.
29. INCHAUSPÉ, G., ZEBEDEE, S., LEE, D. H., SUGITANI, M., NASOFF, M., and PRICE, A. M. (1991). Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates. Proc. Natl. Acad. Sci. USA 88, 10292-10296.
30. KITA, H., HIROISHI, K., MORIYAMA, T., OKAMOTO, H., KANEKO, T., OHNISHI, S., YAZAKI, Y., and IMAWARI, M. (1995). A minimal and optimal cytotoxic T cell epitope within hepatitis C virus nucleoprotein. J. Gen. Virol. 76, 3189-3193.
31. LAGGING, L. M., MEYER, K., HOFT, D., HOUGHTON, M., BELSHE, R. B., and RAY, R. (1995). Immune responses to plasmid DNA encoding the hepatitis C virus core protein. J. Virol. 69, 5859-5863.
32. LAMBERT, V., CHASSOT, S., KAY, A., TRÉPO, C., and COVA L. (1991). In vitro neutralisation of duck hepatitis B virus by antibodies specific to the N-terminal portion of pre-S protein. Virology 185, 446-450.
33. LARGE, M. K., KITTLESEN, D. J., and HAHN, Y. S. (1999). Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatis C virus persistence. J. Immunol. 162, 931-938.
34. LIN, K.-Y., GUARNIERI, F. G., STAVELEY-O'CARROLL, K. F., LEVITSKY, H. I., AUGUST, J. T., PARDOLL D. M., and WU, T.-C. (1996). Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res. 56, 21-26.
35. MICHALEK, M. T., GRANT, E. P., GRAMM, C., GOLDBERG, A. L., and ROCK, K. L. (1993). A role for the ubiquitin-dependent proteolytic pathway in MHC class I-restricted antigen presentation. Nature 363, 552-554.
36. MISSALE, G., BERTONI, R., LAMONACA, V., VALLI, A., MASSARI, M., MORI, C., RUMI, M. G., HOUGHTON, M., FIACCADORI, F., and FERRARI C. (1996). Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J. Clin. Invest. 98, 706-714.
37. NAKANO, I., MAERTENS, G., MAJOR, M. E., VITVITSKI, L., DUBUISSON, J., FOURNILLIER, A., DE MARTYNOFF, G., TRÉPO, C., and INCHAUSPÉ, G. (1997). Immunization with plasmid DNA encoding hepatitis C virus envelope E2 antigenic domains induces antibodies whose immune reactivity is linked to the injection mode. J. Virol. 71, 7101-7109.
38. NASOFF, M. S., ZEBEDEE, S. L., INCHAUSPÉ, G., and PRINCE, A. M. (1991). Identification of an immunodominant epitope within the capsid protein of hepatitis C virus. Proc. Natl. Acad. Sci. USA 88, 5462-5466.
39. + T cell recognition. J. Exp. Med. 171, 875-887.
40. QIU, Y., XU, X., WANDINGER-NESS, A., DALKE, D. P., and PIERCE, S. K. (1994). Separation of subcellular compartments containing distinct functional forms of MHC class II. J. Cell. Biol. 125, 595-605.
41. REHERMANN, B., CHANG, K.-M., McHUTCHINSON, J., KOKKA, R., HOUGHTON, M., RICE, C. M., and CHISARI, F. V. (1996). Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J. Virol. 70, 7092-7102.
42. RODRIGUEZ, F., ZHANG, J., and WHITTON, J. L. (1997). DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction. J. Virol. 71, 8497-8503.
43. ROWELL, J. F., STANHOPE, P. E., and SILICIANO, R. F. (1995). Endocytosis of endogenously synthesized HIV-1 envelope protein: mechanism and role in processing for association with class II MHC. J. Immunol. 155, 473-488.
44. RUFF, A. L., GUARNIERI, F. G., STAVELEY-O'CARROLL, K., SILICIANO, R. F., and AUGUST, J. T. (1997). The enhanced immune response to the HIV gp160/LAMP chimeric gene product targeted to the lysosome membrane protein trafficking pathway. J. Biol. Chem. 272, 8671-8678.
45. SAITO, I., MIYAMURA, T., OHBAYASHI, A., HARADA, H., KATAYAMA, T., KIKUCHI, S., WATANABE, Y., KOI, S., ONJI, M., OHTA, Y., CHOO, Q.-L., HOUGHTON, M., and KUO, G. (1990). Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 87, 6547-6549.
46. SHIRAI, M., OKADA, H., NISHIOKA, M., AKATSUKA, T., WYCHOWSKI, C., HOUGHTEN, R., PENDLETON, C. D., FEINSTONE, S. M., and BERZOFSKY, J. A. (1994). An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. J. Virol. 68, 3334-3342.
47. TANAKA, T., LAU, I. Y. N., MIZOKAMI, M., ORITO, E., TANAKA, E., KIYOSAWA, K., and YASUI, K. (1995). Simple fluorescent enzyme immunoassay for detection and quantification of hepatitis C viremia. J. Hepatol. 23, 742-745.
48. TOBERY, T., and SILICIANO, R. F. (1999). Induction of enhanced CTL-dependent protective immunity in vivo by N-end rule targeting of a model tumor antigen. J. Immunol. 162, 639-642.
49. TOBERY, T. W., and SILICIANO R. F. (1997). Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization. J. Exp. Med. 185, 909-920.
50. TOKUSHIGE, K., WAKITA, T., PACHUK, C., MORADPOUR, D., WEINER, D. B., ZURAWSKI, V. R. JR., and WANDS, J. R. (1996). Expression and immune response to hepatitis C virus core DNA-based vaccine constructs. Hepatology 24, 14-20.
51. VARSHAVSKY, A. (1996). The N-end rule: functions, mysteries, uses. Proc. Natl. Acad. Sci. USA 93, 12142-12149.
52. WEISSMAN, A. M. (1997). Regulating protein degradation by ubiquitination. Immunol. Today 18, 189-198.
53. WU, T.-C., GUARNIERI, F. G., STAVELEY-O'CARROLL, K. F., VISCIDI, R. P., LEVITSKY, H. I., HEDRICK, L., CHO, K. R., AUGUST, J. T., and PARDOLL, D. M. (1995). Engineering an intracellular pathway for major histocompatiblity complex class II presentation of antigens. Proc. Natl. Acad. Sci. USA 92, 11671-11675.
54. WU, Y. and KIPPS, T. J. (1997). Deoxyribonucleoic acid vaccines encoding antigens with rapid proteasome-dependent degradation are highly efficient inducers of cytolytic T lymphocytes. J. Immunol. 159, 6037-6043.